Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

OMI vs MCK

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OMI
Owens & Minor, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$171M
5Y Perf.-71.8%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$91.09B
5Y Perf.+423.9%

OMI vs MCK — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OMI logoOMI
MCK logoMCK
IndustryMedical - DistributionMedical - Distribution
Market Cap$171M$91.09B
Revenue (TTM)$2.76B$397.96B
Net Income (TTM)$-1.10B$4.34B
Gross Margin3.4%
Operating Margin1.0%1.3%
Forward P/E2.3x19.1x
Total Debt$320M$7.39B
Cash & Equiv.$282M$5.69B

OMI vs MCKLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OMI
MCK
StockMay 20Feb 26Return
Owens & Minor, Inc. (OMI)10028.2-71.8%
McKesson Corporation (MCK)100523.9+423.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: OMI vs MCK

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MCK leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Owens & Minor, Inc. is the stronger pick specifically for valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
OMI
Owens & Minor, Inc.
The Value Play

OMI is the clearest fit if your priority is value.

  • Lower P/E (2.3x vs 19.1x)
Best for: value
MCK
McKesson Corporation
The Income Pick

MCK carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 17 yrs, beta 0.04, yield 0.4%
  • Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
  • 351.9% 10Y total return vs OMI's -86.1%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK16.2% revenue growth vs OMI's -74.2%
ValueOMI logoOMILower P/E (2.3x vs 19.1x)
Quality / MarginsMCK logoMCK1.1% margin vs OMI's -39.8%
Stability / SafetyMCK logoMCKBeta 0.04 vs OMI's 1.44
DividendsMCK logoMCK0.4% yield; 17-year raise streak; the other pay no meaningful dividend
Momentum (1Y)MCK logoMCK+5.0% vs OMI's -70.9%
Efficiency (ROA)MCK logoMCK5.3% ROA vs OMI's -44.9%, ROIC 5.4% vs 1.8%

OMI vs MCK — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OMIOwens & Minor, Inc.
FY 2025
Diabetes Product
56.9%$783M
Product and Service, Other
20.9%$288M
Wound Care
13.7%$189M
Urology
8.4%$116M
MCKMcKesson Corporation
FY 2025
U.S. Pharmaceutical Segment
91.3%$327.7B
International Segment
4.1%$14.7B
Medical-Surgical Solutions Segment
3.2%$11.4B
Prescription Technology Solutions
1.5%$5.2B

OMI vs MCK — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMCKLAGGINGOMI

Income & Cash Flow (Last 12 Months)

MCK leads this category, winning 4 of 5 comparable metrics.

MCK is the larger business by revenue, generating $398.0B annually — 144.1x OMI's $2.8B. MCK is the more profitable business, keeping 1.1% of every revenue dollar as net income compared to OMI's -39.8%. On growth, MCK holds the edge at +11.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…
RevenueTrailing 12 months$2.8B$398.0B
EBITDAEarnings before interest/tax$277M$5.8B
Net IncomeAfter-tax profit-$1.1B$4.3B
Free Cash FlowCash after capex-$353M$10.1B
Gross MarginGross profit ÷ Revenue+3.4%
Operating MarginEBIT ÷ Revenue+1.0%+1.3%
Net MarginNet income ÷ Revenue-39.8%+1.1%
FCF MarginFCF ÷ Revenue-12.8%+2.5%
Rev. Growth (YoY)Latest quarter vs prior year-146.3%+11.4%
EPS Growth (YoY)Latest quarter vs prior year+4.5%+38.2%
MCK leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

OMI leads this category, winning 4 of 4 comparable metrics.

On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than MCK's 18.5x.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…
Market CapShares × price$171M$91.1B
Enterprise ValueMkt cap + debt − cash$209M$92.8B
Trailing P/EPrice ÷ TTM EPS-0.16x28.91x
Forward P/EPrice ÷ next-FY EPS est.2.31x19.06x
PEG RatioP/E ÷ EPS growth rate0.74x
EV / EBITDAEnterprise value multiple1.70x18.53x
Price / SalesMarket cap ÷ Revenue0.06x0.25x
Price / BookPrice ÷ Book value/share
Price / FCFMarket cap ÷ FCF17.43x
OMI leads this category, winning 4 of 4 comparable metrics.

Profitability & Efficiency

MCK leads this category, winning 5 of 7 comparable metrics.

On the Piotroski fundamental quality scale (0–9), MCK scores 6/9 vs OMI's 2/9, reflecting solid financial health.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…
ROE (TTM)Return on equity-21.1%
ROA (TTM)Return on assets-44.9%+5.3%
ROICReturn on invested capital+1.8%+5.4%
ROCEReturn on capital employed+1.3%+30.5%
Piotroski ScoreFundamental quality 0–926
Debt / EquityFinancial leverage
Net DebtTotal debt minus cash$38M$1.7B
Cash & Equiv.Liquid assets$282M$5.7B
Total DebtShort + long-term debt$320M$7.4B
Interest CoverageEBIT ÷ Interest expense-0.12x25.04x
MCK leads this category, winning 5 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

MCK leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in MCK five years ago would be worth $40,840 today (with dividends reinvested), compared to $668 for OMI. Over the past 12 months, MCK leads with a +5.0% total return vs OMI's -70.9%. The 3-year compound annual growth rate (CAGR) favors MCK at 26.8% vs OMI's -49.9% — a key indicator of consistent wealth creation.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…
YTD ReturnYear-to-date-3.4%-9.6%
1-Year ReturnPast 12 months-70.9%+5.0%
3-Year ReturnCumulative with dividends-87.4%+104.0%
5-Year ReturnCumulative with dividends-93.3%+308.4%
10-Year ReturnCumulative with dividends-86.1%+351.9%
CAGR (3Y)Annualised 3-year return-49.9%+26.8%
MCK leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

MCK leads this category, winning 2 of 2 comparable metrics.

MCK is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MCK currently trades 74.4% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…
Beta (5Y)Sensitivity to S&P 5001.44x0.04x
52-Week HighHighest price in past year$9.55$999.00
52-Week LowLowest price in past year$1.84$637.00
% of 52W HighCurrent price vs 52-week peak+23.5%+74.4%
RSI (14)Momentum oscillator 0–10046.525.8
Avg Volume (50D)Average daily shares traded690K737K
MCK leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

MCK leads this category, winning 1 of 1 comparable metric.

Wall Street rates OMI as "Hold" and MCK as "Buy". Consensus price targets imply 78.6% upside for OMI (target: $4) vs 35.3% for MCK (target: $1007). MCK is the only dividend payer here at 0.36% yield — a key consideration for income-focused portfolios.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$4.00$1006.50
# AnalystsCovering analysts1031
Dividend YieldAnnual dividend ÷ price+0.4%
Dividend StreakConsecutive years of raises017
Dividend / ShareAnnual DPS$2.69
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.5%
MCK leads this category, winning 1 of 1 comparable metric.
Key Takeaway

MCK leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OMI leads in 1 (Valuation Metrics).

Best OverallMcKesson Corporation (MCK)Leads 5 of 6 categories
Loading custom metrics...

OMI vs MCK: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is OMI or MCK a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.

2% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). McKesson Corporation (MCK) offers the better valuation at 28. 9x trailing P/E (19. 1x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OMI or MCK?

On forward P/E, Owens & Minor, Inc.

is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — OMI or MCK?

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +308.

4%, compared to -93. 3% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: MCK returned +351. 9% versus OMI's -86. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OMI or MCK?

By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.

04β versus Owens & Minor, Inc. 's 1. 44β — meaning OMI is approximately 3251% more volatile than MCK relative to the S&P 500.

05

Which is growing faster — OMI or MCK?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.

2% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: McKesson Corporation grew EPS 14. 9% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, MCK leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OMI or MCK?

McKesson Corporation (MCK) is the more profitable company, earning 0.

9% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 0. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCK leads at 1. 2% versus 1. 0% for OMI. At the gross margin level — before operating expenses — MCK leads at 3. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OMI or MCK more undervalued right now?

On forward earnings alone, Owens & Minor, Inc.

(OMI) trades at 2. 3x forward P/E versus 19. 1x for McKesson Corporation — 16. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 78. 6% to $4. 00.

08

Which pays a better dividend — OMI or MCK?

In this comparison, MCK (0.

4% yield) pays a dividend. OMI does not pay a meaningful dividend and should not be held primarily for income.

09

Is OMI or MCK better for a retirement portfolio?

For long-horizon retirement investors, McKesson Corporation (MCK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

04), +351. 9% 10Y return). Both have compounded well over 10 years (MCK: +351. 9%, OMI: -86. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OMI and MCK?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: OMI is a small-cap quality compounder stock; MCK is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

OMI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

MCK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OMI and MCK on the metrics below

Revenue Growth>
%
(OMI: -146.3% · MCK: 11.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.